GSK-Pfizer deal gets conditional approval by South Africa's watchdog
MLex Summary: The South African competition authority has conditionally approved the acquisition of Pfizer's consumer healthcare business by GlaxoSmithKline Consumer Healthcare. The authority found that the deal may affect local manufacturers of pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article